Ana Vaz is a Global Strategy and Clinical Development Leader in Neuroscience with extensive experience at Eli Lilly and Company, where Ana served as Associate Vice President of Regulatory Affairs for North America from 2022 to 2024. Previously, Ana held various roles, including Director of Strategic Competitive Intelligence and Global Development Leader in Incretins Neuroscience. Ana began her career in clinical research and epidemiology with positions at Wayne State University School of Medicine and Núcleo Mama Porto Alegre. Ana earned a Master of Public Health and a Bachelor of Science from the University of Michigan.
This person is not in the org chart
This person is not in any teams
This person is not in any offices